Skip to main content

Grafa News and Videos — Page 1446

Latest

Grafa

Moderna initiates Phase 3 trial for H5 pandemic flu vaccine to bolster global readiness

Moderna (NASDAQ:MRNA) announced a significant milestone in global health security on April 22, 2026, with the dosing of the first participants in the United States and the United Kingdom for its Phase 3 clinical trial of mRNA-1018.

Read more: Moderna initiates Phase 3 trial for H5 pandemic flu vaccine to bolster global readiness

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift